<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-DrugBank.d448">
    <sentence id="DDI-DrugBank.d448.s0" text="MAO inhibitors prolong and intensify the effects of antihistamines.">
        <entity id="DDI-DrugBank.d448.s0.e0" charOffset="0-13"
            type="group" text="MAO inhibitors"/>
        <entity id="DDI-DrugBank.d448.s0.e1" charOffset="52-65"
            type="group" text="antihistamines"/>
        <ddi id="DDI-DrugBank.d448.s0.d0" e1="DDI-DrugBank.d448.s0.e0"
            e2="DDI-DrugBank.d448.s0.e1" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d448.s1" text="Concomitant use of antihistamines with alcohol, tricyclic antidepressants, barbiturates, or other central nervous system depressants may have an additive effect.">
        <entity id="DDI-DrugBank.d448.s1.e0" charOffset="19-32"
            type="group" text="antihistamines"/>
        <entity id="DDI-DrugBank.d448.s1.e1" charOffset="39-45"
            type="drug" text="alcohol"/>
        <entity id="DDI-DrugBank.d448.s1.e2" charOffset="48-72"
            type="group" text="tricyclic antidepressants"/>
        <entity id="DDI-DrugBank.d448.s1.e3" charOffset="75-86"
            type="group" text="barbiturates"/>
        <entity id="DDI-DrugBank.d448.s1.e4" charOffset="98-131"
            type="group" text="central nervous system depressants"/>
        <ddi id="DDI-DrugBank.d448.s1.d0" e1="DDI-DrugBank.d448.s1.e0"
            e2="DDI-DrugBank.d448.s1.e1" type="effect"/>
        <ddi id="DDI-DrugBank.d448.s1.d1" e1="DDI-DrugBank.d448.s1.e0"
            e2="DDI-DrugBank.d448.s1.e2" type="effect"/>
        <ddi id="DDI-DrugBank.d448.s1.d2" e1="DDI-DrugBank.d448.s1.e0"
            e2="DDI-DrugBank.d448.s1.e3" type="effect"/>
        <ddi id="DDI-DrugBank.d448.s1.d3" e1="DDI-DrugBank.d448.s1.e0"
            e2="DDI-DrugBank.d448.s1.e4" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d448.s2" text="When sympathomimetic drugs are given to patients receiving monoamine oxidase inhibitors, hypertensive reactions, including hypertensive crises, may occur.">
        <entity id="DDI-DrugBank.d448.s2.e0" charOffset="5-25"
            type="group" text="sympathomimetic drugs"/>
        <entity id="DDI-DrugBank.d448.s2.e1" charOffset="59-86"
            type="group" text="monoamine oxidase inhibitors"/>
        <ddi id="DDI-DrugBank.d448.s2.d0" e1="DDI-DrugBank.d448.s2.e0"
            e2="DDI-DrugBank.d448.s2.e1" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d448.s3" text="The antihypertensive effects of methyldopa, mecamylamine, reserpine, and veratrum alkaloids may be reduced by sympathomimetics.">
        <entity id="DDI-DrugBank.d448.s3.e0" charOffset="32-41"
            type="drug" text="methyldopa"/>
        <entity id="DDI-DrugBank.d448.s3.e1" charOffset="44-55"
            type="drug" text="mecamylamine"/>
        <entity id="DDI-DrugBank.d448.s3.e2" charOffset="58-66"
            type="drug" text="reserpine"/>
        <entity id="DDI-DrugBank.d448.s3.e3" charOffset="73-90"
            type="drug" text="veratrum alkaloids"/>
        <entity id="DDI-DrugBank.d448.s3.e4" charOffset="110-125"
            type="group" text="sympathomimetics"/>
        <ddi id="DDI-DrugBank.d448.s3.d0" e1="DDI-DrugBank.d448.s3.e0"
            e2="DDI-DrugBank.d448.s3.e4" type="effect"/>
        <ddi id="DDI-DrugBank.d448.s3.d1" e1="DDI-DrugBank.d448.s3.e1"
            e2="DDI-DrugBank.d448.s3.e4" type="effect"/>
        <ddi id="DDI-DrugBank.d448.s3.d2" e1="DDI-DrugBank.d448.s3.e2"
            e2="DDI-DrugBank.d448.s3.e4" type="effect"/>
        <ddi id="DDI-DrugBank.d448.s3.d3" e1="DDI-DrugBank.d448.s3.e3"
            e2="DDI-DrugBank.d448.s3.e4" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d448.s4" text="Beta-adrenergic blocking agents may also interact with sympathomimetics.">
        <entity id="DDI-DrugBank.d448.s4.e0" charOffset="0-30"
            type="group" text="Beta-adrenergic blocking agents"/>
        <entity id="DDI-DrugBank.d448.s4.e1" charOffset="55-70"
            type="group" text="sympathomimetics"/>
        <ddi id="DDI-DrugBank.d448.s4.d0" e1="DDI-DrugBank.d448.s4.e0"
            e2="DDI-DrugBank.d448.s4.e1" type="int"/>
    </sentence>
    <sentence id="DDI-DrugBank.d448.s5" text="Increased ectopic pacemaker activity can occur when pseudoephedrine is used concomitantly with digitalis.">
        <entity id="DDI-DrugBank.d448.s5.e0" charOffset="52-66"
            type="drug" text="pseudoephedrine"/>
        <entity id="DDI-DrugBank.d448.s5.e1" charOffset="95-103"
            type="group" text="digitalis"/>
        <ddi id="DDI-DrugBank.d448.s5.d0" e1="DDI-DrugBank.d448.s5.e0"
            e2="DDI-DrugBank.d448.s5.e1" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d448.s6" text="Antacids increase the rate of absorption of pseudoephedrine, while kaolin decreases it.">
        <entity id="DDI-DrugBank.d448.s6.e0" charOffset="0-7"
            type="group" text="Antacids"/>
        <entity id="DDI-DrugBank.d448.s6.e1" charOffset="44-58"
            type="drug" text="pseudoephedrine"/>
        <entity id="DDI-DrugBank.d448.s6.e2" charOffset="67-72"
            type="drug" text="kaolin"/>
        <ddi id="DDI-DrugBank.d448.s6.d0" e1="DDI-DrugBank.d448.s6.e0"
            e2="DDI-DrugBank.d448.s6.e1" type="mechanism"/>
        <ddi id="DDI-DrugBank.d448.s6.d1" e1="DDI-DrugBank.d448.s6.e1"
            e2="DDI-DrugBank.d448.s6.e2" type="mechanism"/>
    </sentence>
</document>
